{"id":72661,"date":"2023-07-10T19:35:02","date_gmt":"2023-07-10T17:35:02","guid":{"rendered":"https:\/\/www.fedaiisf.it\/?p=72661"},"modified":"2023-07-10T19:35:02","modified_gmt":"2023-07-10T17:35:02","slug":"assosalute-rapporto-2023-sui-farmaci-che-non-necessitano-di-prescrizione","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/assosalute-rapporto-2023-sui-farmaci-che-non-necessitano-di-prescrizione\/","title":{"rendered":"Absolutehealth. Over-the-counter drugs report 2023"},"content":{"rendered":"

Assosalute has published the 2023 report on the numbers and indices of self-medication drugs. The relationship yes
\n\"\"<\/a>structure in 5 chapters. It starts from a European-level examination of the health and economic situation, to then narrow the focus to the Italian pharmaceutical market in 2022 and therefore to the market for products that do not require a prescription. The fourth chapter focuses on the 2023-25 spending trends of the "non-prescription" market and then analyzes the characteristics of the market and the players in the sector.<\/em><\/p>\n

Let's leave out the European market and bring back the Italian market<\/em><\/p>\n

The Italian market<\/h2>\n

Sales data for 2022 show a dispensing of just under 1.8 billion packs of medicines, for a value of more than 17 billion euros<\/strong>. The data was positive for both prescription and non-prescription drugs. The increase in spending was higher for the latter (+19%) than for the former (+2.1%). "As regards the packs dispensed<\/strong>, the trends are similar to those with values: prescription drugs show a moderately positive trend<\/strong> (+2.0%), while non-prescription medicines show a marked increase, with a double-digit increase (+15.9%)\u00bb reads the report.<\/p>\n

2022 strengthened the positive trend that had already started in April 2021, thanks to the easing of the restrictive measures imposed by Covid-19, the recovery of the circulation of flu and flu-like viruses. More generally, by the incidence of non-serious disorders. As for the market, the pharmacy has a stable market share of 89% in volumes and 90.5% in values of non-prescription medicines<\/strong>. Although growing, e-commerce is still marginal in this sector.<\/p>\n

The innovation of the market "non-prescription\u201d<\/em><\/h2>\n

Compared with the traditional pharmaceutical market, that non-prescription<\/em> shows more contained margins of innovation, even if the companies in the sector invest constantly in order to innovate and renew the drugs already on the market, to optimize their dosages and forms of administration and, therefore, their effectiveness<\/strong>, reducing any contraindications and interactions. It follows that they are frequently \"\"medicines placed on the market whose active ingredient has been on the market for years, but with new pharmaceutical forms or combinations. In terms of turnover, 54.1% is represented by packs launched in 2000 while those launched since 2010 represent 36% of total sales.<\/p>\n

The 5 most used product categories<\/h2>\n

In terms of products, the five therapeutic categories with the highest incidence of expenditure and consumption (90.1% of packages sold and 87.2% of expenditure) are those of medicines for the treatment of colds, analgesics, gastrointestinal medicines, dermatologicals and medicines for the circulatory system<\/strong>.<\/p>\n

Trends 2023-2025<\/h2>\n

In view of the given conditions, it is a growth trend is expected for the current year (+9.7%), a positive trend which, albeit at lower rates, will also be maintained in the years to come (+5% and +3.8% respectively in 2024 and 2025)<\/strong>. At the 'basket' level, in the absence of changes of a regulatory nature, no changes are expected in the composition of expenditure. Finally, geographically, non-prescription drugs will maintain their current configuration: 50% in the North, 21% in the Center and 27% in the South.<\/p>\n

Source Pharmacy News of July 10, 2023<\/a><\/p>\n

NUMBERS AND INDEXES OF SELF-MEDICATION \u2013 ED. 2023<\/h2>\n
\n

Chapter 1
\n<\/strong>The health and pharmaceutical picture in Europe in 2022<\/p>\n

Infographic 1\u00a0<\/a>\u00a0\u00a0 <\/a>Infographic 2<\/a><\/p>\n

\"\"Chapter 2
\n<\/strong>The pharmaceutical market in Italy in 2022<\/p>\n

Infographic 1<\/a>\u00a0\u00a0\u00a0Infographic 2\u00a0\u00a0\u00a0<\/a><\/p>\n

Chapter 3
\n<\/strong>The market non-prescription<\/em> in Italy in 2022
\nInfographic 1\u00a0<\/a><\/p>\n

Chapter 4
\n<\/strong>Forecasts on the expenditure and consumption of non-prescription drugs: the three-year period 2023-2025
\nInfographic 1\u00a0<\/a><\/p>\n

Chapter 5
\n<\/strong>Economic structure of the pharmaceutical sector non-prescription<\/em> and market players
\nInfographic 1<\/a>\u00a0\u00a0\u00a0 Infographic 2\u00a0\u00a0<\/a><\/p>\n

Appendix<\/strong>
\nRegulatory framework<\/p>\n<\/div>\n

\n

DOWNLOADS<\/h2>\n